References
- Bagley, S. M., Peterson, J., Cheng, D. M., Jose, C., Quinn, E., O’Connor, P. G., & Walley, A. Y. (2015). Overdose education and naloxone rescue kits for family members of individuals who use opioids: Characteristics, motivations, and naloxone use. Substance Abuse, 36(2), 149–154. https://doi.org/https://doi.org/10.1080/08897077.2014.989352
- Bernstein, K. T., Bucciarelli, A., Piper, T. M., Gross, C., Tardiff, K., & Galea, S. (2007). Cocaine-and opiate-related fatal overdose in New York City, 1990–2000. BMC Public Health, 7(1), 31. https://doi.org/https://doi.org/10.1186/1471-2458-7-31
- Bohnert, A. S., Tracy, M., & Galea, S. (2009). Circumstances and witness characteristics associated with overdose fatality. Annals of Emergency Medicine, 54(4), 618–624. https://doi.org/https://doi.org/10.1016/j.annemergmed.2009.05.004
- Centers for Disease Control and Prevention [CDC]. (2020a). Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. CDC Health Alert Network. https://emergency.cdc.gov/han/2020/han00438.asp
- Centers for Disease Control and Prevention [CDC]. (2020b). CDC wonder. https://wonder.cdc.gov/
- Cerdá, M., Ransome, Y., Keyes, K. M., Koenen, K. C., Tracy, M., Tardiff, K. J., Vlahov, D., & Galea, S. (2013). Prescription opioid mortality trends in New York City, 1990–2006: Examining the emergence of an epidemic. Drug and Alcohol Dependence, 132(1–2), 53–62. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2012.12.027
- Ciccarone, D. (2019). The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. International Journal of Drug Policy, 71, 183–188. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.01.010
- D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015). Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: A randomized clinical trial. JAMA, 313(16), 1636–1644. https://doi.org/https://doi.org/10.1001/jama.2015.3474
- Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R., & Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention. Journal of Urban Health, 80(2), 261–273. https://doi.org/https://doi.org/10.1093/jurban/jtg029
- DeBeck, K., Small, W., Wood, E., Li, K., Montaner, J., & Kerr, T. (2009). Public injecting among a cohort of injecting drug users in Vancouver, Canada. Journal of Epidemiology & Community Health, 63(1), 81–86. https://doi.org/https://doi.org/10.1136/jech.2007.069013
- Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009). Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. American Journal of Public Health, 99(5), 788–791. https://doi.org/https://doi.org/10.2105/AJPH.2008.146647
- Ford, E., Carroll, J. A., Smith, H. E., Scott, D., & Cassell, J. A. (2016). Extracting information from the text of electronic medical records to improve case detection: A systematic review. Journal of the American Medical Informatics Association, 23(5), 1007–1015. https://doi.org/https://doi.org/10.1093/jamia/ocv180
- Fozouni, L., Buchheit, B., Walley, A. Y., Testa, M., & Chatterjee, A. (2019). Public restrooms and the opioid epidemic. Substance Abuse, 41(4), 1–5. https://doi.org/https://doi.org/10.1080/08897077.2019.1640834
- Fusaro, V. A., Levy, H. G., & Shaefer, H. L. (2018). Racial and ethnic disparities in the lifetime prevalence of homelessness in the United States. Demography, 55(6), 2119–2128. https://doi.org/https://doi.org/10.1007/s13524-018-0717-0
- Geiger, C., Smart, R., & Stein, B. D. (2019). Who receives naloxone from emergency medical services? Characteristics of calls and recent trends. Substance Abuse, 41(3), 1–8. https://doi.org/https://doi.org/10.1080/08897077.2019.1640832
- Gostin, L. O., Hodge, J. G., & Gulinson, C. L. (2019). Supervised injection facilities: Legal and policy reforms. JAMA, 321(8), 745–746. https://doi.org/https://doi.org/10.1001/jama.2019.0095
- Keane, C., Egan, J. E., & Hawk, M. (2018). Effects of naloxone distribution to likely bystanders: Results of an agent-based model. International Journal of Drug Policy, 55, 61–69. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.02.008
- Klee, H., & Morris, J. (1995). Factors that characterize street injectors. Addiction, 90(6), 837–841. https://doi.org/https://doi.org/10.1046/j.1360-0443.1995.90683712.x
- Lambdin, B. H., Zibbell, J., Wheeler, E., & Kral, A. H. (2018). Identifying gaps in the implementation of naloxone programs for laypersons in the United States. International Journal of Drug Policy, 52, 52–55. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.11.017
- Latkin, C. A., Dayton, L., Davey-Rothwell, M. A., & Tobin, K. E. (2019). Fentanyl and drug overdose: Perceptions of fentanyl risk, overdose risk behaviors, and opportunities for intervention among people who use opioids in Baltimore, USA. Substance Use & Misuse, 54(6), 998–1006. https://doi.org/https://doi.org/10.1080/10826084.2018.1555597
- Madah-Amiri, D., Skulberg, A. K., Braarud, A. C., Dale, O., Heyerdahl, F., Lobmaier, P., & Clausen, T. (2019). Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facility. Substance Abuse, 40(3), 383–388. https://doi.org/https://doi.org/10.1080/08897077.2018.1485130
- Mahon, L. R., Hawthorne, A. N., Lee, J., Blue, H., & Palombi, L. (2018). Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: Illuminating barriers to pharmacist-led harm reduction. Harm Reduction Journal, 15(1), 57. https://doi.org/https://doi.org/10.1186/s12954-018-0262-6
- McGuire, A. B., Powell, K. G., Treitler, P. C., Wagner, K. D., Smith, K. P., Cooperman, N., Robinson, L., Carter, J., Ray, B., & Watson, D. P. (2020). Emergency department-based peer support for opioid use disorder: Emergent functions and forms. Journal of Substance Abuse Treatment, 108, 82–87. https://doi.org/https://doi.org/10.1016/j.jsat.2019.06.013
- Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017 (NCHS data brief no. 328). https://www.cdc.gov/nchs/data/databriefs/db328-h.pdf
- National Institute of Drug Abuse [NIDA]. (2019). Overdose death rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
- New Jersey Department of Law and Public Safety [NJDPLS], Office of the Attorney General. (2020). NJCARES: A realtime dashboard of opioid-related data and information. https://www.njcares.gov/
- Olfson, M., Crystal, S., Wall, M., Wang, S., Liu, S. M., & Blanco, C. (2018). Causes of death after nonfatal opioid overdose. JAMA Psychiatry, 75(8), 820–827. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2018.2102
- Olfson, M., Wall, M., Wang, S., Crystal, S., & Blanco, C. (2018). Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug and Alcohol Dependence, 190, 112–119. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.06.004
- Powell, K. G., Treitler, P., Peterson, N. A., Borys, S., & Hallcom, D. (2019). Promoting opioid overdose prevention and recovery: An exploratory study of an innovative intervention model to address opioid abuse. International Journal of Drug Policy, 64, 21–29. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.12.004
- Siegler, A., Tuazon, E., O’Brien, D. B., & Paone, D. (2014). Unintentional opioid overdose deaths in New York City, 2005–2010: A place-based approach to reduce risk. International Journal of Drug Policy, 25(3), 569–574. https://doi.org/https://doi.org/10.1016/j.drugpo.2013.10.015
- Singh, G. K. (2003). Area deprivation and widening inequalities in US mortality, 1969–1998. American Journal of Public Health, 93(7), 1137–1143. https://doi.org/https://doi.org/10.2105/ajph.93.7.1137
- Slavova, S., Rock, P., Bush, H. M., Quesinberry, D., & Walsh, S. L. (2020). Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug and Alcohol Dependence, 214, 108176. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108176
- StataCorp. (2013). Stata: Release 13 (Statistical Software).
- Stein, M. D., Kenney, S. R., Anderson, B. J., & Bailey, G. L. (2019). Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use. Journal of Substance Abuse Treatment, 104, 144–147. https://doi.org/https://doi.org/10.1016/j.jsat.2019.07.006
- Stirling, S. (2016). Segregated N.J., a look at how race still divides us. https://www.nj.com/news/2016/06/segregated_nj_a_look_at_how_race_still_divides_us.html
- Sutter, A., Curtis, M., & Frost, T. (2019). Public drug use in eight US cities: Health risks and other factors associated with place of drug use. International Journal of Drug Policy, 64, 62–69. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.11.007
- Suzuki, J., & El-Haddad, S. (2017). A review: Fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence, 171, 107–116. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.11.033
- Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020). Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy, 75, 102536. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.07.031
- Tracy, M., Piper, T. M., Ompad, D., Bucciarelli, A., Coffin, P. O., Vlahov, D., & Galea, S. (2005). Circumstances of witnessed drug overdose in New York City: Implications for intervention. Drug and Alcohol Dependence, 79(2), 181–190. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2005.01.010
- U.S. Census Bureau. (2018). 2017 American Community Survey 5-year estimates. https://www.census.gov/newsroom/press-kits/2018/acs-5year.html
- Vivolo-Kantor, A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., Kite-Powell, A., & Coletta, M. A. (2018). Vital signs: Trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017. Morbidity and Mortality Weekly Report, 67(9), 279. https://doi.org/https://doi.org/10.15585/mmwr.mm6709e1
- Volkow, N. (2020). Collison of the COVID-19 and addictions epidemics. Annals of Internal Medicine, 173(1), 61–62. https://doi.org/https://doi.org/10.7326/M20-1212
- Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346(jan30 5), f174. https://doi.org/https://doi.org/10.1136/bmj.f174
- Weiner, J., Murphy, S. M., & Behrends, C. (2019). Expanding access to naloxone: A Review of distribution strategies. https://repository.upenn.edu/ldi_issuebriefs/132/
- Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(23), 631. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584734/
- Woolf, S. H., & Schoomaker, H. (2019). Life expectancy and mortality rates in the United States, 1959–2017. JAMA, 322(20), 1996–2016. https://doi.org/https://doi.org/10.1001/jama.2019.16932